News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
173 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (18004)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
2 (104)
3 (173)
4 (173)
5 (128)
6 (1)
7 (23)
8 (258)
9 (151)
10 (98)
11 (90)
12 (52)
13 (1)
14 (1)
15 (70)
16 (158)
17 (130)
18 (132)
19 (69)
20 (4)
21 (3)
22 (130)
23 (153)
24 (124)
25 (141)
26 (79)
27 (1)
28 (1)
29 (133)
30 (155)
31 (147)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Effective April 1, 2018: OraSure CEO to Retire, New Leader Named
The Company also announced updated revenue guidance for the fourth quarter of 2017.
January 4, 2018
·
10 min read
Business
ChemDiv, DZNE and Torrey Pines Investment Launch Inflammasome Discovery Program of Translational Collaboration on Neurodegeneration
The overall goal of the collaboration is to leverage DZNE’s advanced research capabilities with ChemDiv’s commercial expertise to efficiently design and validate new therapeutic candidates for treatment of Alzheimer’s and other neurodegenerative diseases.
January 4, 2018
·
3 min read
Business
AvantGen and Tanabe Research Laboratories Expand Collaboration for Therapeutic Antibody Discovery
Under the terms of the collaboration, AvantGen is responsible for generating novel antibodies to specified cancer targets using its proprietary human antibody yeast display technology platform.
January 4, 2018
·
3 min read
Drug Development
Asterias Biotherapeutics Reports Milestone Targets for 2018
These achievements, combined with the Company’s financial resources position Asterias to achieve the following milestones during 2018.
January 4, 2018
·
6 min read
Policy
Alimera Sciences Receives Acceptance of Filing to Obtain Approval for ILUVIEN Non-Infectious Posterior Uveitis Indication in Europe
Alimera submitted the results from two, randomized, double-masked, multi-center phase 3 clinical trials.
January 4, 2018
·
6 min read
Oculis Raises CHF20 Million in a Series B Financing Round to Advance Breakthrough Treatments for Ophthalmic Diseases
The financing was led by a syndicate of leading international life science investors including Bay City Capital, Novartis Venture Fund and Pivotal bioVenture Partners.
January 4, 2018
·
3 min read
Pharm Country
Feinstein Institute Researcher Awarded $1.2M to Continue Sepsis Research
Feinstein Institute for Medical Research Professor Haichao Wang, PhD, received a $1.2M grant from the NIH NIGMS to continue his search to identify different proteins associated with sepsis, which could lead to a targeted treatment for the condition.
January 4, 2018
·
2 min read
Business
MacroGenics Nabs $380M Pact With Drug Giant Roche
In the deal, both companies will leverage their respective platforms, including MacroGenics’ DART platform and Roche’s CrossMAb and DutaFab technologies to select a bispecific format and lead product candidate.
January 4, 2018
·
3 min read
Drug Development
Ultragenyx Announces Update to UX007 Development Program in Long-Chain Fatty Acid Oxidation Disorder Patients
The company expects that a decision on a potential filing for approval based on Phase 2 data will be made in mid-2018.
January 4, 2018
·
7 min read
Pharming Announces Further Conversion of its Ordinary Convertible Bonds
The newly issued shares represent 4.6% of the outstanding share capital immediately prior to the issue.
January 4, 2018
·
5 min read
Previous
17 of 18
Next